What is the status of higenamine
Unfortunately, given the costs that go into clinical trials and the fact that potentially hundreds of thousands of people are already taking these peptides (so theres already a market driving profit), theres a strong possibility that a new robust clinical trial may never be done on BPC-157
They inhibit the transcriptional activity of C/EBP/
Conflict of interest JT has given Scientific advice to AlfaWassermann, Allergan, Christian Hansen, Danone, Grnenthal, Ironwood, Janssen, Kiowa Kirin, Menarini, Mylan, Neutec, Novartis, Noventure, Nutricia, Shionogi, Shire, Takeda, Theravance, Tramedico, Truvion, Tsumura, Zealand, and Zeria pharmaceuticals and has served on the Speaker bureau for Abbott, Allergan, AstraZeneca, Janssen, Kyowa Kirin, Menarini, Mylan, Novartis, Shire, Takeda, Truvion, and Zeria
Its not overnight, but most people are glad they did it
Several drugs, including colchicine, have been reported to reduce the absorption of methylcobalamin, vitamin B12